AMNEAL PHARMACEUTICALS INC (AMRX) Stock Price, Quote, News and Overview
NASDAQ:AMRX - Nasdaq - US03168L1052 - Common Stock - Currency: USD
AMRX Quote, Performance and Key Statistics
8.9
+0.14 (+1.6%)
The current stock price of AMRX is 8.9 USD. In the past month the price increased by 11.67%. In the past year, price increased by 65.12%.
AMRX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 66.89 | 824.51B | ||
| JNJ | JOHNSON & JOHNSON | 16.69 | 401.33B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 26.18 | 386.95B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 21.41 | 240.28B | ||
| MRK | MERCK & CO. INC. | 12.39 | 239.09B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.56 | 228.26B | ||
| PFE | PFIZER INC | 8.59 | 151.49B | ||
| SNY | SANOFI-ADR | 14.24 | 148.55B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 53.59 | 123.97B | ||
| GSK | GSK PLC-SPON ADR | 8.29 | 81.62B | ||
| ZTS | ZOETIS INC | 28.78 | 76.29B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 33.71 | 47.88B |
Related stock screener links
About AMRX
Company Profile
Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. The company is headquartered in Bridgewater, New Jersey and currently employs 7,700 full-time employees. The company went IPO on 2009-11-18. Its Generics segment includes a retail and institutional portfolio of over 270 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
Company Info
AMNEAL PHARMACEUTICALS INC
400 Crossing Boulevard, 3rd Floor
Bridgewater NEW JERSEY 08807 US
CEO: Chirag Patel
Employees: 7850
Company Website: https://amneal.com/
Investor Relations: http://investors.amneal.com/investor-relations/default.aspx
Phone: 19089473120
AMNEAL PHARMACEUTICALS INC / AMRX FAQ
What is the stock price of AMNEAL PHARMACEUTICALS INC today?
The current stock price of AMRX is 8.9 USD. The price increased by 1.6% in the last trading session.
What is the ticker symbol for AMNEAL PHARMACEUTICALS INC stock?
The exchange symbol of AMNEAL PHARMACEUTICALS INC is AMRX and it is listed on the Nasdaq exchange.
On which exchange is AMRX stock listed?
AMRX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for AMNEAL PHARMACEUTICALS INC stock?
10 analysts have analysed AMRX and the average price target is 11.22 USD. This implies a price increase of 26.07% is expected in the next year compared to the current price of 8.9. Check the AMNEAL PHARMACEUTICALS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is AMNEAL PHARMACEUTICALS INC worth?
AMNEAL PHARMACEUTICALS INC (AMRX) has a market capitalization of 2.76B USD. This makes AMRX a Mid Cap stock.
How many employees does AMNEAL PHARMACEUTICALS INC have?
AMNEAL PHARMACEUTICALS INC (AMRX) currently has 7850 employees.
What are the support and resistance levels for AMNEAL PHARMACEUTICALS INC (AMRX) stock?
AMNEAL PHARMACEUTICALS INC (AMRX) has a support level at 8.25 and a resistance level at 8.91. Check the full technical report for a detailed analysis of AMRX support and resistance levels.
Is AMNEAL PHARMACEUTICALS INC (AMRX) expected to grow?
The Revenue of AMNEAL PHARMACEUTICALS INC (AMRX) is expected to grow by 8.53% in the next year. Check the estimates tab for more information on the AMRX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy AMNEAL PHARMACEUTICALS INC (AMRX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AMRX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AMRX, evaluating the profitability, health, valuation and growth aspects
- AMNEAL PHARMACEUTICALS INC (AMRX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AMNEAL PHARMACEUTICALS INC (AMRX) Sales and EPS estimates to see what analysts future expectations are.
- AMNEAL PHARMACEUTICALS INC (AMRX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AMNEAL PHARMACEUTICALS INC (AMRX) Insider and Institutional Ownership to learn about the owners and their transactions.
- AMNEAL PHARMACEUTICALS INC (AMRX) Stock Chart to make your own analysis
- AMNEAL PHARMACEUTICALS INC (AMRX) Latest news and press-releases to stay up to date.
Does AMNEAL PHARMACEUTICALS INC (AMRX) stock pay dividends?
AMRX does not pay a dividend.
What is the Price/Earnings (PE) ratio of AMNEAL PHARMACEUTICALS INC (AMRX)?
The PE ratio for AMNEAL PHARMACEUTICALS INC (AMRX) is 15.34. This is based on the reported non-GAAP earnings per share of 0.58 and the current share price of 8.9 USD. Check the full fundamental report for a full analysis of the valuation metrics for AMRX.
What is the Short Interest ratio of AMNEAL PHARMACEUTICALS INC (AMRX) stock?
The outstanding short interest for AMNEAL PHARMACEUTICALS INC (AMRX) is 1.88% of its float. Check the ownership tab for more information on the AMRX short interest.
AMRX Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to AMRX. When comparing the yearly performance of all stocks, AMRX is one of the better performing stocks in the market, outperforming 94.28% of all stocks.
AMRX Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to AMRX. There are concerns on the financial health of AMRX while its profitability can be described as average.
AMRX Financial Highlights
Over the last trailing twelve months AMRX reported a non-GAAP Earnings per Share(EPS) of 0.58. The EPS decreased by -9.37% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.42% | ||
| ROE | -424.61% | ||
| Debt/Equity | 134.73 |
AMRX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 82% to AMRX. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of 23.85% and a revenue growth 8.53% for AMRX